Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("HORI, Masatsugu")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 231

  • Page / 10
Export

Selection :

  • and

Tolvaptan for Heart Failure Patients with Volume OverloadHORI, Masatsugu.Cardiovascular drugs and therapy. 2011, Vol 25, issn 0920-3206, S1-S4, SUP1Article

An arginine-vasopressin V2 receptor antagonist, Tolvaptan for treatment of heart failure with volume overload - Evidence from nonclinical studies to clinical trialsHORI, Masatsugu.Cardiovascular drugs and therapy. 2011, Vol 25, issn 0920-3206, 100 p., SUP1Serial Issue

Efficacy and Safety of Tolvaptan in Heart Failure Patients with Sustained Volume Overload despite the Use of Conventional Diuretics: A Phase III Open-Label StudyFUKUNAMI, Masatake; MATSUZAKI, Masunori; HORI, Masatsugu et al.Cardiovascular drugs and therapy. 2011, Vol 25, issn 0920-3206, S47-S56, SUP1Article

Efficacy and Safety of Tolvaptan in Heart Failure Patients with Volume Overload Despite the Standard Treatment with Conventional Diuretics: A Phase III, Randomized, Double-blind, Placebo-controlled Study (QUEST Study)MATSUZAKI, Masunori; HORI, Masatsugu; IZUMI, Tohru et al.Cardiovascular drugs and therapy. 2011, Vol 25, issn 0920-3206, S33-S45, SUP1Article

Oxidative stress and left ventricular remodelling after myocardial infarction : A transnational approach to myocardial remodellingHORI, Masatsugu; NISHIDA, Kazuhiko.Cardiovascular research. 2009, Vol 81, Num 3, pp 457-464, issn 0008-6363, 8 p.Article

Phase III Clinical Pharmacology Study of TolvaptanINOMATA, Takayuki; IZUMI, Tohru; MATSUZAKI, Masunori et al.Cardiovascular drugs and therapy. 2011, Vol 25, issn 0920-3206, S57-S65, SUP1Article

Effects of Tolvaptan on Volume Overload in Japanese Patients with Heart Failure: Results of a Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group StudyMATSUZAKI, Masunori; HORI, Masatsugu; IZUMI, Tohru et al.Cardiovascular drugs and therapy. 2011, Vol 25, issn 0920-3206, S19-S31, SUP1Article

Cerebral ischemia in 5-lipoxygenase knockout miceKITAGAWA, Kazuo; MATSUMOTO, Masayasu; HORI, Masatsugu et al.Brain research. 2004, Vol 1004, Num 1-2, pp 198-202, issn 0006-8993, 5 p.Article

Multicenter prospective investigation on cardiovascular adverse effects of tacrolimus in kidney transplantationsSEINO, Yoshihiko; HORI, Masatsugu; SONODA, Takao et al.Cardiovascular drugs and therapy. 2003, Vol 17, Num 2, pp 141-149, issn 0920-3206, 9 p.Article

The importance of manganese superoxide dismutase in delayed preconditioning: Involvement of reactive oxygen species and cytokinesHOSHIDA, Shiro; YAMASHITA, Nobushige; OTSU, Kinya et al.Cardiovascular research. 2002, Vol 55, Num 3, pp 495-505, issn 0008-6363Article

Repeated physiologic stresses provide persistent cardioprotection against ischemia-reperfusion injury in ratsHOSHIDA, Shiro; YAMASHITA, Nobushige; OTSU, Kinya et al.Journal of the American College of Cardiology. 2002, Vol 40, Num 4, pp 826-831, issn 0735-1097Article

Fr167653, a cytokine-suppressive agent, reduces myocardial ischemia-reperfusion injury in ratsHOSHIDA, Shiro; YAMASHITA, Nobushige; OTSU, Kinya et al.Cytokines, cellular & molecular therapy. 2000, Vol 6, Num 4, pp 165-170, issn 1368-4736Article

Nonclinical Pharmacokinetics of a New Nonpeptide V2 Receptor Antagonist, TolvaptanFURUKAWA, Masayuki; UMEHARA, Ken; KASHIYAMA, Eiji et al.Cardiovascular drugs and therapy. 2011, Vol 25, issn 0920-3206, S83-S89, SUP1Article

5. Future aspects of gene therapy in acute ischemic strokeKITAGAWA, Kazuo; HORI, Masatsugu; MATSUMOTO, Masayasu et al.Internal medicine (Tokyo. 1992). 2005, Vol 44, Num 4, pp 371-374, issn 0918-2918, 4 p.Article

Bone marrow is a reservoir of repopulating mesangial cells during glomerular remodelingITO, Takahito; SUZUKI, Akira; IMAI, Enyu et al.Journal of the American Society of Nephrology. 2001, Vol 12, Num 12, pp 2625-2635, issn 1046-6673Article

C-reactive protein predicts carotid atherosclerosis progression in mild to moderate risk and middle-aged patientsHASHIMOTO, Hiroyuki; KITAGAWA, Kazuo; HOUGAKU, Hidetaka et al.Clinical and investigative medicine. 2006, Vol 29, Num 2, pp 77-82, issn 0147-958X, 6 p.Article

Electroporation-mediated gene transfer that targets glomeruliTSUJIE, Michiko; ISAKA, Yoshitaka; NAKAMURA, Hiroyuki et al.Journal of the American Society of Nephrology. 2001, Vol 12, Num 5, pp 949-954, issn 1046-6673Article

Relationship between C-reactive protein and progression of early carotid atherosclerosis in hypertensive subjectsHASHIMOTO, Hiroyuki; KITAGAWA, Kazuo; HOUGAKU, Hidetaka et al.Stroke (1970). 2004, Vol 35, Num 7, pp 1625-1630, issn 0039-2499, 6 p.Article

Application of bone marrow-derived stem cells in experimental nephrologyITO, Takahito; SUZUKI, Akira; OKABE, Masaru et al.Experimental nephrology. 2001, Vol 9, Num 6, pp 444-450, issn 1018-7782Article

Delayed, but marked, expression of apolipoprotein E is involved in tissue Clearance after cerebral infarctionKITAGAWA, Kazuo; MATSUMOTO, Masayasu; KUWABARA, Keisuke et al.Journal of cerebral blood flow and metabolism. 2001, Vol 21, Num 10, pp 1199-1207, issn 0271-678XArticle

Determination of coronary zero flow pressure by analysis of the baseline pressure : Flow relationship in humansNANTO, Shinsuke; MASUYAMA, Tohru; TAKANO, Yuzuru et al.Japanese Circulation Journal. 2001, Vol 65, Num 9, pp 793-796, issn 0047-1828Article

Protective and regenerative response endogenously induced in the ischemic brain : New strategies for combating cerebral ischemia = Nouvelles stratégies de lutte contre l'ishémie cérébraleKITAGAWA, Kazuo; MATSUMOTO, Masayasu; HORI, Masatsugu et al.Canadian journal of physiology and pharmacology. 2001, Vol 79, Num 3, pp 262-265, issn 0008-4212Conference Paper

Anti-edematous Effects of Tolvaptan in Experimental Rodent ModelsMIYAZAKI, Toshiki; SAKAMOTO, Yuki; YAMASHITA, Tatsuya et al.Cardiovascular drugs and therapy. 2011, Vol 25, issn 0920-3206, S77-S82, SUP1Article

A persistent increase in C-reactive protein is a risk factor for restenosis in patients with stable angina who are not receiving statinsHOSHIDA, Shiro; NISHINO, Masami; TAKEDA, Toshihiro et al.Atherosclerosis. 2004, Vol 173, Num 2, pp 285-290, issn 0021-9150, 6 p.Article

Tornado extraction: A method to enrich and purify RNA from the nephrogenic zone of the neonatal rat kidneyITO, Takahito; SUZUKI, Akira; IMAI, Enyu et al.Kidney international. 2002, Vol 62, Num 3, pp 763-769, issn 0085-2538Article

  • Page / 10